Host intestinal immune response

The host intestinal immune response is a specialized branch of the immune system designed to maintain homeostasis within the gastrointestinal tract while defending against pathogenic threats. It involves a sophisticated interplay between the intestinal epithelium, the gut microbiota, and the gut-associated lymphoid tissue (GALT), which contains a high concentration of T cells, B cells, and innate immune cells (Mowat & Agace, 2014, Nature Reviews Immunology). Dysregulation of this response, often characterized by a loss of tolerance to commensal microbes, is a primary driver of chronic inflammatory conditions such as Crohn's disease and ulcerative colitis (Abraham & Cho, 2009, New England Journal of Medicine). Pharmacological intervention typically targets specific molecular mediators within this response, such as tumor necrosis factor (TNF) or specific interleukins, to dampen pathological inflammation (Danese et al., 2015, Nature Reviews Gastroenterology & Hepatology). Because it is a physiological process rather than a single molecular entity, it is considered a broad therapeutic area rather than a specific drug target.

Other names

Mucosal immune systemGut-associated lymphoid tissue responseIntestinal immunityGastrointestinal immune response

Modulation of the intestinal immune response occurs through various mechanisms, including the neutralization of pro-inflammatory cytokines (e.g., TNF-alpha, IL-12, IL-23), inhibition of leukocyte trafficking to the gut mucosa via integrin antagonism, and inhibition of intracellular signaling pathways like the JAK-STAT pathway.